medigraphic.com
ISSN 1561-2937 (Print)

2021, Number 1

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2021; 27 (1)

Factors Associated with Hospital Mortality in Patients with Pulmonary Hypertension Undergoing Cardiac Surgery

Alonso HA, Ceballos AA, Fuentes HL, Pérez BK

Language: Spanish
References: 26
Page: 1-7
PDF size: 168.85 Kb.


ABSTRACT

Introduction: Pulmonary Hypertension in the field of Cardiac Surgery is a risk factor for complications and mortality.
Objective: To describe the Clinical Finding and variables related to mortality in patients with pulmonary Hypertension undergoing Cardiac Surgery.
Methods: Descriptive, cross-sectional studies, 92 patients assessed with pulmonary hypertension undergoing cardiac surgery.
Results: Female patients represented the 55,91% vs. 44,09% male; 94,62% survived vs. 5,38% died who 4,30% presented as combined valve disease; 33.33% of all patients had mitral regurgitation, 31,18% mitral stenosis and 23,66% combined valve disease. There was not statistically relationship between etiology and mortality (P = 0.123). Functional Class II presented in 76.34%, 22,58% class III and only 1,08% class I. Class III was present in all deceased patients. There was a significant relationship between functional class and mortality (P = 0,03).
Statistically different was shown between the hours of mechanical ventilation of the deceased (88 hours) and those who survived (33.3 hours), (P = 0.00), as well as in time of Extracorporeal Circulation 174,6 min vs. 99,9 min (P = 0.003). Significant statistically differences were also found between the right ventricular function (ESPAT) 19,3 mm vs 13,8 mm (P = 0,002).
Conclusions: There is a relationship between the mortality of patients with pulmonary hypertension and the functional class at the time of surgery, the deceased patients showed more hours of mechanical ventilation, longer cardiopulmonary bypass time and impaired systolic function of the right ventricle.


REFERENCES

  1. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R; the EuroSCORE study group. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9-13.

  2. Nazzareno G, Humber M, Vachieryc JL, Gibbs S, Lang I, Torbicki A et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). European Heart Journal. 2016; 37: 67–119.

  3. Bernstein AD, Parsonnet V. Bedside estimation of risk as an aid for decisionmaking in cardiac surgery. Ann Thorac Surg. 2000;69:823-8.

  4. R Condliffe MD* and DG Kiely MD. Critical care management of pulmonary hypertension. BJA Education. 2017; 7: 228–234.

  5. Koulova A, Gass AL, Patibandla S, Gupta CA, Aronow GS, Lanier GM. Management of pulmonary hypertension from left heart disease in candidates for orthotopic heart transplantation. J Thorac Dis 2017;9(8):2640-2649. Bootsma IT, et al.

  6. Bootsma IT, De Lange F, Koopmans M, Haenen J, Boonstra PW, Symersky T, Boerma EC. Right Ventricular Function After Cardiac Surgery Is a Strong Independent Predictor for Long-Term Mortality. Journal of Cardiothoracic and Vascular Anesthesia. 2017; 5: 1656-1662.

  7. Winterhalter M, Antoniou T, Loukanov T. Management of adult patients with perioperative pulmonary hypertension: technical aspects and therapeutic options.Cardiology. 2010;116:3-9.

  8. Yutaka F. Evaluation of Inflammation Caused by Cardiopulmonary Bypass in a Small Animal Model. Biology 2020; 9: 8.

  9. Nieto Estradaa VH, Molano Francoa DL, Valencia Morenoa AA , Rojas Gambasicaa JA , Cortes Nuneza CC. Postoperative Right Ventricular Failure in Cardiac Surgery. Cardiol Res. 2016;7(6):185-195.

  10. 10 .Wanner PM, Filipovic M. The Right Ventricle—You May Forget It, But It Will Not Forget You. J. Clin. Med. 2020, 9, 432.

  11. Mandoli GE, Cameli1 M, Novo G, Agricola E, Righini FM, Santoro S. Right ventricular function after cardiac surgery: the diagnostic and prognostic role of echocardiography. Heart Fail Rev. 2019; 24:625–635.

  12. Seo JS, So KY, Kim SH. Perioperative anesthetic considerations in patients with pulmonary hypertension undergoing non-cardiac and non-obstetric surgeries. Med Biol Sci Eng. 2019;2(2):31-39.

  13. Magne J, Mathieu P, Dumesnil JG, Tanné D, Dagenais F, Doyle D, et al. Impact of prosthesis-patient mismatch on survival after mitral valve replacement. Circulation. 2007;115:1417-25.

  14. Monaco F, Di Prima AL, Kim JH, Plamondon M, Yavorovskiy A, Likhvantsev V, Lomivorotov V et al. Management of Challenging Cardiopulmonary Bypass Separation. Journal of Cardiothoracic and Vascular Anesthesia. 2020; 34:1622-1635.

  15. Zochios V, Protopapas AD, Parhar K. Markers of Right Ventricular Dysfunction in Adult Cardiac Surgical Patients. Journal of Cardiothoracic and Vascular Anesthesia. 2017; 31: 1570–1574.

  16. 16 Itagaki S, Hosseinian L, Varghese R. Right Ventricular Failure After Cardiac Surgery: Management Strategies. 2012; 24(3): 188-194.

  17. Harjola1 V, Mebazaa A, Celutkien J, Bettex D, Bueno H, Chioncel O et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology European Journal of Heart Failure, 2016; 18:226–241.

  18. Daniel H. Enter, Anthony Zaki, Brett F. Duncan, Jane Kruse, Adin-Cristian Andrei, Zhi Li. Contemporary analysis of pulmonary hypertension in patients undergoing mitral valve surgery: Is this a risk factor?. J Thorac Cardiovasc Surg 2016;151:1288-99.

  19. Song X, Zhang C, Chen X, Chen Y, Shi1Q, Niu Y, Xiao J et al. An excellent result of surgical treatment in patients with severe pulmonary arterial hypertension following mitral valve disease. Journal of Cardiothoracic Surgery. 2015; 10:70.

  20. Da Silva PS, Trindade Cartacho MP, Cardoso de Castro C, Fonseca Salgado Filho M, Aguiar Brandão AC. Evaluation of the influence of pulmonary hypertension in ultra-fast-track anesthesia technique in adult patients undergoing cardiac surgery. Braz J Cardiovasc Surg 2015;30(4):449-58.

  21. Kennedy JLW, LaPar DJ, Kern JA, Kron IL, Bergin JD, Kamath S, Ailawadi G. Does the Society of Thoracic Surgeons risk score accurately predict operative mortality for patients with pulmonary hypertension?. J Thorac Cardiovasc Surg 2013;146:631-7.

  22. Akca B, Erdil N, Murat Disli O, Donmez K, Erdil F, Cengiz Colak M, Battaloglu B. Coronary Bypass Surgery in Patients with Pulmonary Hypertension: Assessment of Early and Long Term Results. Ann Thorac Cardiovasc Surg 2015; 21: 268-274.

  23. Zlotnick DM, Ouellette ML, Malenka DJ, DeSimone JP, Leavitt BJ, Helm RE. Effect of Preoperative Pulmonary Hypertension on Outcomes in Patients With Severe Aortic Stenosis Following Surgical Aortic Valve Replacement. Am J Cardiol 2013;15;112(10):1635-40.

  24. Prakash Borde D, Asegaonkar B, Khade S, Puranik M. AntonyGeorge2,Shreedhar Joshi3 Impact of preoperative pulmonary arterial hypertension on early and late outcomes in patients undergoing valve surgery for rheumatic heart disease. Indian J Anaesth. 2018; 62(12): 963–971.

  25. Bootsma IT, Scheeren, WL, de Lange, F, Johannes H, Boonstra PW, Christaan BE. Impaired right ventricular ejection fraction after cardiac surgery is associated with a complicated ICU stay. Journal of Intensive Care. 2018; 6:85.

  26. F. Roques, Nashef P, Michel E, Gauducheau C, de Vincentiis E, Baudet J. Cortina, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. European Journal of Cardio-thoracic Surgery .1999; 15(6):816-22.




2020     |     www.medigraphic.com